|
|
|
|||
| Home Help Feedback Subscriptions Archive Search Table of Contents | ||||
First published online 30 July 2008
doi: 10.1242/dev.021121
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Laboratory of Embryonic Stem Cell Research, Stem Cell Research Center,
Institute for Frontier Medical Sciences, Kyoto University, 53 Kawahara-cho,
Shogoin, Sakyo-ku, Kyoto 606-8507, Japan.
2 Department of Development and Differentiation, Institute for Frontier Medical
Sciences, Kyoto University, 53 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto
606-8507, Japan.
3 Institute for Integrated Cell-Material Sciences (iCeMS), Kyoto University, 69
Konoe-cho, Yoshida, Sakyo-ku, Kyoto 606-8507, Japan.
* Author for correspondence (e-mail: hsuemori{at}frontier.kyoto-u.ac.jp)
Accepted 3 July 2008
| SUMMARY |
|---|
|
|
|---|
Key words: Primitive streak, Mesoderm, Endoderm, Stem cells, β-Catenin, Wnt
| INTRODUCTION |
|---|
|
|
|---|
The canonical Wnt signaling functions are well established in fundamental
biological processes (Moon et al.,
2004
; Tam and Loebel,
2007
). In early embryogenesis, Wnt/β-catenin signaling has
pivotal roles in the formation of the PS, mesoderm and endoderm
(Lickert et al., 2002
;
Tam and Loebel, 2007
), and the
stabilization of β-catenin leads to premature EMT in mouse embryo
(Kemler et al., 2004
). Wnt
binds to its receptor Frizzled and co-receptor Lrp5/6, and increases the level
of cytoplasmic and nuclear β-catenin, followed by inhibition of the
GSK3-mediated degradation pathway. Upon inhibition of GSK3 activity,
stabilized β-catenin translocates into the nucleus, where it serves as a
co-activator of the Lef/Tcf family of DNA-binding proteins to form active
transcriptional complexes for specific target genes
(Moon et al., 2004
). There is
accumulating evidence that the Wnt/β-catenin signaling pathway also has
an important role in stem cell maintenance and regulation of the cell fate
decision in several stem cell systems, including hematopoietic, epidermal and
intestinal stem cells (Moon et al.,
2004
).
Embryonic stem (ES) cells possess the remarkable property of indefinite
self-renewal and pluripotency, the ability to differentiate to all cell types
of an organism; they also provide an excellent model system for studying cell
fate determination in early mammalian development
(Keller, 2005
). Multiple
signaling pathways, such as those involving growth factors, transcriptional
regulators and epigenetic modifiers, have crucial roles in regulating the
balance between ES-cell self-renewal and lineage commitment
(Keller, 2005
). It is very
important to elucidate molecular mechanisms of the self-renewal and lineage
commitment for efficient production of functional cells required for use of
hES cells in transplantation therapy and drug discovery. Like other stem cell
systems, canonical Wnt/β-catenin signaling is implicated in mouse ES
(mES) cell self-renewal and differentiation, depending on the context
(Gadue et al., 2006
;
Hao et al., 2006
;
Lindsley et al., 2006
), but
precise roles of this signaling in human ES (hES) cells remains controversial
(Dravid et al., 2005
;
Sato et al., 2004
).
We report here that the activation of canonical Wnt/β-catenin signaling in hES cells by conditional activation of stabilized β-catenin disrupted hES-cell self-renewal. Rather, the canonical Wnt/β-catenin and BMP signaling pathway in hES cells has significant roles in establishing the posterior PS/mesoderm progenitors, whereas attenuation of BMP signaling changes the cell fate to the anterior PS/endoderm progenitors. In addition, Activin and Wnt/β-catenin signaling pathways synergistically function in inducing undifferentiated hES cells to differentiate into the anterior PS/endoderm progenitors. This is the first in vitro model system that consistently recapitulates the human early embryogenesis and that enables us to analyze molecular events during the process of early embryogenesis from the epiblast to the PS formation, followed by lineage specification into the mesoderm and endoderm. More importantly, our findings will also be relevant to directed differentiation of specific tissue and cells from hES cells.
| MATERIALS AND METHODS |
|---|
|
|
|---|
Nβ-cateninER construct, in which the N-terminal 90 amino
acids were deleted, was generated by in-frame insertion into the expression
vector containing the hormone-binding domain of a mutant estrogen receptor
(Littlewood et al., 1995
Nβ-cateninER were obtained by transfection of hES cell
lines KhES-1 and KhES-3 with
Nβ-cateninER expression plasmids,
followed by puromysin selection as described previously
(Sumi et al., 2007
Nβ-cateninER, hES cells stably expressing
Nβ-cateninER were treated with 4OHT (100 nM), as indicated.
Maintenance and differentiation of hES cells
The hES cell line HES-3 was purchased from ES Cell International. The hES
cell lines KhES-1, KhES-3 and HES-3 were maintained as described previously
(Suemori et al., 2006
). For
differentiation of hES cells, the cells were dissociated into small clumps and
cultured on plates coated with matrigel (BD Biosciences, San Jose, CA) in
DMEM/F12 with N2 and B27 supplements (Invitrogen, Carlsbad, CA). The next day,
the medium was changed to N2B27 medium with or without 4OHT (100 nM, Sigma, St
Louis, MO) in the presence or absence of 250 ng/ml Noggin-Fc chimera (R&D
Systems Minneapolis, MN) except as otherwise indicated, and renewed daily
thereafter. For Activin-induced differentiation, hES cells were cultured in
RPMI supplemented with 2% FBS in the presence or absence of 100 ng/ml Activin
A (R&D Systems), 100 ng/ml DKK1 (R&D Systems) or 100 nM 4OHT for 3
days, and then analyzed as described below. SB431542 (Sigma), U0126 and
LY294002 (Promega, Madison, WI) were used at a final concentration of 10
µM. GSK-3 inhibitor-IX and -X (BIO and BIO-Acetoxime, Calbiochem, La Jolla,
CA) were used at a final concentration of 2 to 10 µM. For endothelial cell
differentiation, cells cultured with 4OHT for 3 days were trypsinized and
plated on collagen I-coated dishes, and then cultured in a StemPro34 serum
free medium (Invitrogen) with 20 ng/ml VEGF165 (R&D Systems) for an
additional 6 days. For endoderm and cardiac differentiation,
β-catenin-activated cells cultured with or without Noggin (250 ng/ml) for
4 days were trypsinized and plated on collagen I-coated dishes, and then
cultured in a N2B27 medium without 4OHT in the presence of 10 ng/ml BMP4
(R&D Systems) and 5 ng/ml FGF2 for an additional 4 days. All data shown
are representative results obtained from at least two independent clones of
two different human ES cell lines.
Quantitative and semi-quantitative PCR analysis
Total RNA was isolated from cells using RNeasy Micro Kit (QIAGEN, Valencia,
VA) and reverse-transcribed using Omniscript RT Kit (QIAGEN) according to the
manufacturer's protocol. For semi-quantitative PCR, PCR reactions were
optimized to allow for semi-quantitative comparisons within the log phase of
amplification. Real-time RT-PCR analysis was performed on an ABI Prism 7500
Real-time PCR system using the PowerSYBR Green PCR Master Mix (Applied
Biosystems, Foster City, CA). The expression value of each gene was normalized
against the amount of GAPDH and calculated by the 
Ct method. The
expression level of each gene in the control sample (vehicle or
undifferentiated ES cells) was defined as 1.0. The normalized expression
values for all control and treated samples were averaged, and average
fold-change was determined. Details of the primers used for the
semi-quantitative and quantitative PCR can be provided on request.
Western blot and immunofluorescence analysis
Cell lysates were prepared and subjected to sodium dodecyl
sulfate-polyacrylamide gel elctrophoresis (SDS-PAGE), followed by western
blotting as described previously (Sumi et
al., 2007
). For immunofluorescence analysis, cells plated on the
culture slides were fixed with 3.7% formaldehyde and permeabilized with 0.25%
Triton X-100. After blocking, the cells were incubated with primary
antibodies, followed by incubation with secondary antibodies. Alexa Fluor 488-
or 555-conjugated secondary antibodies were purchased from Invitrogen. Cells
were mounted onto glass slides with Vectashield (Vector Laboratories,
Burlingame, CA), and then analyzed using a BX61 fluorescence microscope
(Olympus, Center Valley, PA). Antibodies against the following proteins were
used: VEGF R2/KDR (clone#89115), SOX17 and CXCR4 (clone#44717) (R&D
Systems); E-cadherin, Smad2/3, GSK3β and β-catenin (BD Biosciences);
N-cadherin (GC-4, Sigma); ZO-1 (Invitrogen); Nanog (ReproCELL); HNF3β,
Oct3/4, Brachyury and ER
(Santa Cruz Biotechnology, Santa Cruz, CA);
SSEA3 and SSEA4 (Developmental Hybridoma Bank); TRA-1-60 and TRA-1-81
(Chemicon); Phospho-Smad1 (Ser463/465), Smad1, phospho-Smad2 (Ser465/467),
phospho-MAPK (Thr202/Tyr204), MAPK, phospho-Akt (Ser473), Akt and
phospho-GSK3
/β (Ser21/9) (Cell Signaling, Danvers, MA).
FACS analysis
Single cell suspensions were fixed with 1% formaldehyde for 30 minutes at
4°C, and incubated first with primary antibody and then with Alexa Fluor
488-, 555-conjugated secondary antibody (Invitrogen). FACS analysis was
performed using a FACSCalibur Flow Cytometer (Becton Dickinson).
Karyotype analysis of hES cells
Chromosome spreads were prepared as described elsewhere
(Suemori et al., 2006
).
Briefly, hES cells were incubated in ES medium with KaryoMAX Colcemid Solution
(Invitrogen; 0.1 µg/ml of colcemid) for 2 hours, trypsinized, incubated in
0.075 M KCl for 10 minutes and fixed in Carnoy's fixative.
| RESULTS |
|---|
|
|
|---|
Nβ-cateninER) can be conditionally activated in
response to the ER agonist 4-hydroxy-tamoxifen (4OHT), thus enabling
consistent and reversible activation of β-catenin. We obtained several
independent hES cell clones with stable expression of the
Nβ-cateninER fusion proteins, following the transfection of this
expression plasmid and puromycin selection. Results presented here were
obtained using one or two clones, but similar results were obtained with
further independent clones from two different hES cell lines: KhES-1 and
KhES-3. These transgenic clones had normal karyotype and expressed
cell-surface markers for hES cells, including SSEA3, SSEA4, TRA-1-60, TRA-1-81
and pluripotent markers POU5F1, SOX2 and NANOG
comparable with the parental hES cells (see Fig. S1A-D in the supplementary
material). No obvious effect of 4OHT on the undifferentiated state of parental
hES cells was observed (see Fig. S1B,D in the supplementary material). When
Nβ-cateninER cells were cultured in chemically defined medium
(Yao et al., 2006
Nβ-cateninER cells maintained an undifferentiated state in culture
without 4OHT. In the presence of 4OHT, however, the morphology of the cells
began to differentiate with dissociation of the cell-cell junctions and
induction of cell scattering within 1 to 2 days, resembling the EMT
(Thiery, 2002
|
|
To evaluate the relative proportion of mesoderm progenitors induced by
β-catenin activation, we analyzed the expression of CXCR4 and KDR as
mesoderm markers by fluorescence-activated cell sorting (FACS) analysis. Weak
levels of KDR expression were detected in
50% of undifferentiated ES
cells, while CXCR4 was not expressed (Fig.
2A). A representative 5-day kinetic experiment indicated that the
KDR+/CXCR4+ cells were immediately detected after 2 days
of β-catenin activation. After 3 days of activation, more than 80% of
cells became KDR+/CXCR4+ double positive, and then this
proportion declined between 4 and 5 days. To examine whether the
KDR+/CXCR4+ cells have the potential to differentiate
towards mesoderm derivatives, β-catenin-activated cells at day 3 were
cultured under conditions that induce the endothelial cell lineage with VEGF.
These cells had endothelial cell-like morphology and prominent induction of
endothelial cell markers, including CD34, CDH5 (VE-cadherin),
PECAM, TEK (Tie-2) and VWF (von Willebrand factor)
(Fig. 2B,C). When these
endothelial-like cells were cultured on Matrigel with VEGF, they formed a
meshwork of cells, resembling the capillary-like structures formed by mature
endothelial cells (Fig. 2D).
These results demonstrate that hES-derived mesoderm progenitors induced by
β-catenin have a potential to differentiate into an endothelial cell
lineage.
Antagonism of BMP signaling changes the mesoderm progenitor fate towards the anterior PS
To examine whether BMP and Activin/Nodal signaling are involved in the
β-catenin-mediated formation of PS/mesoderm progenitors, the BMP and
Activin/Nodal signaling pathways were attenuated by Noggin or SB431542 (SB),
which inhibit BMP or Activin/Nodal receptors ALK4/5/7, respectively
(Fig. 3A). In the presence of
Noggin, β-catenin-induced expression of the mesoderm markers KDR,
FOXF1 and VENTX, and of the PS marker MIXL1, which is
also expressed in the posterior PS/mesoderm
(Robb et al., 2000
), was
markedly diminished, whereas Noggin consistently enhanced the expression of
T and GSC (Fig.
3A; see Fig. S2 in the supplementary material). By contrast,
exposure of cells to SB in the presence of 4OHT prevented the induction of
differentiation markers, except for T and trophectoderm marker
CGA. These findings demonstrate the requirement of both BMP and
Activin/Nodal signaling pathway for the β-catenin-induced mesoderm
formation in differentiating hES cells. Intriguingly, in contrast to the
abolished mesoderm induction by Noggin, BMP signaling blockade induced the
expression of the anterior PS/endoderm markers FOXA1, FOXA2, CER1,
SHH and SOX17 (Fig.
3A) (D'Amour et al.,
2005
; Kanai-Azuma et al.,
2002
; Kubo et al.,
2004
; Yasunaga et al.,
2005
). The visceral endoderm marker SOX7, ectoderm marker
PAX6 and trophectoderm marker CGA were not induced in
Noggin-treated cells, indicating that they did not differentiate into the
visceral endoderm, ectoderm and trophectoderm lineages. Immunofluorescence
analysis indicated that more than 70% of FOXA2-positive cells were observed
only following combined Noggin and β-catenin activation, and they were
co-expressed with Brachyury and SOX17 (Fig.
3B).
|
myosin heavy chain (MYH6)] was prominently induced only in
the Noggin-treated cells (Fig.
3C). These results indicate that β-catenin-activated cells
treated with Noggin possess the characteristic of anterior PS/endoderm
progenitors similar to that of mouse ES cells and embryo
(Gadue et al., 2006To determine the optimal requirement of β-catenin and Noggin for generation of mesoderm and the anterior PS progenitors, cells were cultured with these factors for various time periods and then analyzed for gene expression. Induction of T, GSC and FOXA2, and inhibition of mesoderm (KDR) was dependent on the Noggin dose (see Fig. S2A in the supplementary material), and not observed in the absence of 4OHT, indicating the necessity for both β-catenin activation and BMP signaling inhibition in the cell fate change toward the anterior PS progenitors. The expression of T and GSC and mesoderm marker FOXF1 was upregulated within 1 day of β-catenin activation, and reached peak levels by continuous 3 days of activation. The addition of Noggin repressed expression of the FOXF1 gene, whereas the expression of the T, GSC and FOXA2 genes was induced to maximal levels 3 days after β-catenin activation (see Fig. S2B in the supplementary material). Thus, transient activation of β-catenin in hES cells was sufficient to induce mesoderm progenitors, but continuous activation was required for maximal induction of mesoderm markers. In contrast to the requirement for β-catenin, the last 2 days of Noggin treatment were sufficient to inhibit FOXF1 and to induce FOXA2, although continuous treatment of Noggin needed for maximal induction of T and GSC (see Fig. S2C in the supplementary material).
|
In addition to the SMADs pathway, accumulating evidence indicates that
SMAD-independent pathways are involved in TGFβ signaling
(Derynck and Zhang, 2003
). BMP
signaling has an antagonistic role in the canonical Wnt/β-catenin
signaling pathway through inhibition of the PI3-kinase/Akt signaling pathway
by PTEN (He et al., 2004
;
Kobielak et al., 2007
).
Consistent with the requirement for Akt signaling to maintain ES cell
pluripotency (Watanabe et al.,
2006
), an active form of Akt (P-Akt) was observed in
undifferentiated hES cells (vehicle), and later downregulated in
β-catenin activated cells (Fig.
4C). There was a slight increase in the inactive form of
GSK3β (P-GSK3β), which is phosphorylated by Akt, in β-catenin
activated cells, regardless of the reduced active form of Akt, suggesting the
involvement of an Akt-independent regulatory pathway
(Etienne-Manneville and Hall,
2003
). By contrast, inhibition of BMP signaling enhanced
phosphorylation of both Akt and GSK3β. Immunofluorescence analysis showed
that total β-catenin was localized at the cell membrane in the absence of
4OHT, whereas
Nβ-cateninER was diffusively distributed within
cells, indicating that the
Nβ-cateninER protein was kept in an
inactive form in the absence of 4OHT (Fig.
4D). When cells were treated with 4OHT,
Nβ-cateninER
was concentrated in the nuclei even in the presence or absence of Noggin
(Fig. 4D). By contrast, total
β-catenin was localized at the cell membrane and slightly in the nucleus
by 4OHT treatment in comparison with vehicle control cells. Conversely, in
Noggin-treated cells, β-catenin was preferentially accumulated in the
cytoplasm and nuclei compared with cell treated with 4OHT alone
(Fig. 4D). These data suggest
that inhibition of BMP signaling by Noggin might enhance the stability of
endogenous β-catenin through the Akt/GSK3β signaling pathway during
the PS specification. The cadherin family modulates nucleo-cytoplasmic
localization, stability and transactivation of β-catenin
(Moon et al., 2004
). An
increased cytoplasmic pool of β-catenin due to disorganized interactions
with cadherin family members might thereby enhance β-catenin-mediated
transactivation. Indeed, expression of T transcript and protein,
which is a direct downstream target of β-catenin
(Yamaguchi et al., 1999
), and
GSC, a direct target of T
(Messenger et al., 2005
), was
enhanced in Noggin-treated cells compared with cells treated with 4OHT alone
(Fig. 3A; see Fig. S2A-C in the
supplementary material). By contrast, Erk1/2 phosphorylation was enhanced in
β-catenin-activated cells, but was even more prominent in BMP-antagonized
cells (Fig. 4C).
It has been shown that inhibition of BMP and FGF/MAPK signaling pathways
potentiates the induction of endoderm in Xenopus and zebrafish
(Poulain et al., 2006
;
Sasai et al., 1996
). To
explore the possible role of the PI3-kinase and MAPK signaling pathways in
cell fate specification induced by β-catenin and BMP antagonism, cells
were cultured in the presence of MEK1/2 (U0126) or PI3-kinase (LY294002)
inhibitors. Consistent with an earlier finding that Erk2 is essential for
mesoderm induction (Yao et al.,
2003
), inhibition of MEK1/2 completely abolished the induction of
mesoderm progenitors (FOXF1), whereas inhibition of PI3-kinase had no
effect on mesoderm induction (Fig.
5A). Interestingly, the expression of FOXA2 was slightly,
but consistently, upregulated by the inhibition of MEK1/2, compared with cells
treated with 4OHT alone, suggesting that uncommitted progenitors change their
cell fate toward the anterior PS progenitors following MEK1/2 signaling
blockade (Fig. 5A). By
contrast, FOXA2 expression induced by the antagonism of BMP signaling
was completely blocked by the inhibition of PI3-kinase, but not MEK1/2,
signaling. Immunofluorescence analysis of FOXA2 protein expression confirmed
the quantitative RT-PCR results (Fig.
5B). Thus, these findings demonstrate that the PI3-kinase, but not
MEK1/2, pathway, is essential for changing the differentiation of
β-catenin-mediated hES cells from mesoderm to the anterior PS
progenitors.
|
Nβ-cateninER (data not shown). It might be due to the fact that
BIO targets various protein kinases, such as Cdk family and MAP kinases
(Meijer et al., 2003
We further examined whether the canonical Wnt/β-catenin is involved in
the specification of mesendoderm/endoderm induced by Activin during hES cell
differentiation, because it has been demonstrated the synergistic interaction
of the canonical Wnt and Nodal/Activin signaling pathway in mesoderm and
endoderm specification in mouse embryo and ES cell system
(Gadue et al., 2006
;
Tam and Loebel, 2007
).
Consistent with a previous report (D'Amour
et al., 2005
), expression of mesendoderm markers (T and
GSC) and definitive endoderm markers (CER1 and
FOXA2) was induced in the presence of a high concentration of Activin
A (Fig. 7A). By contrast,
expression of these mesendoderm/endoderm markers was markedly diminished when
Wnt signaling was inhibited by the addition of DKK1
(Glinka et al., 1998
).
Conversely, activation of
Nβ-cateninER by 4OHT with Activin
enhanced expression of mesendoderm/endoderm markers rather than Activin alone
(Fig. 7B). Immunoblot analysis
showed that phosphorylation of SMAD2 and expression of FOXA2 protein were
enhanced in cells by β-catenin activation with Activin
(Fig. 7C). Taken together,
these data indicate that mesendoderm/endoderm specification of hES cells in
the culture was defined by the cooperative interaction of Wnt/β-catenin
and Activin signaling pathway.
| DISCUSSION |
|---|
|
|
|---|
|
|
Alternatively, there might be a threshold of Wnt/β-catenin activity
involved in the biphasic property of Wnt signaling. Blockade of GSK3β
with higher concentrations of BIO prominently induced nuclear translocation of
β-catenin and mesoderm differentiation of unmanipulated hES cells,
whereas the lower concentrations of BIO seemed to support their self-renewal
(Fig. 6; see Fig. S3A in the
supplementary material). A similar activity-dependent effect of β-catenin
on self-renewal or differentiation was obtained by titrating the 4OHT
concentration (see Fig. S3B in the supplementary material). At the lower
concentrations of 4OHT, which anticipates modest activation of β-catenin,
hES cells were seemingly maintained in a self-renewal state, despite the weak
induction of mesoderm markers, whereas at the higher concentration of 4OHT the
undifferentiated stem cell state of the hES cells was abolished. These
findings are consistent with a model in which small changes in the cellular
levels of crucial transcriptional factors, such as Oct3/4 and PU.1, define the
lineage commitment of stem cells (Gurdon
and Bourillot, 2001
; Laslo et
al., 2006
; Niwa et al.,
2000
). Thus, we propose that the canonical Wnt/β-catenin
signaling in hES cells has biphasic roles in controlling self-renewal and
differentiation, depending on a specific threshold of β-catenin activity,
although distinct properties of the individual hES cell lines reflect
differences in their susceptibility to BIO
(Fig. 6; see Fig. S3 in the
supplementary material).
In summary, we have demonstrated that the canonical Wnt/β-catenin signaling pathway in differentiating hES cells has significant roles in establishing the PS/mesendoderm and mesoderm progenitors, which recapitulates the global developmental program during the early embryogenesis. More importantly, we show that the nascent PS populations changed their cell fate to the anterior PS/endoderm or posterior PS/mesoderm progenitors following modulation of the Activin/Nodal and BMP signaling pathways. Thus, the reciprocal balance of Activin/Nodal and BMP signaling pathways have crucial roles in the cell fate specification of the naive PS/mesendoderm, which is induced by activation of the canonical Wnt/β-catenin signaling in hES cell differentiation (Fig. 7D). Because precise regulation of cell lineages is indispensable for efficient production of functional cells from hES cells, our findings would be valuable for devising methods for such functional cell production. Future studies, such as genome-wide epigenetic and gene expression analysis, will further enhance our understanding of how lineage specification of hES cells is determined.
Supplementary material
Supplementary material for this article is available at
http://dev.biologists.org/cgi/content/full/135/17/2969/DC1
| ACKNOWLEDGMENTS |
|---|
| REFERENCES |
|---|
|
|
|---|
Aubert, J., Dunstan, H., Chambers, I. and Smith, A. (2002). Functional gene screening in embryonic stem cells implicates Wnt antagonism in neural differentiation. Nat. Biotechnol. 20,1240 -1245.[CrossRef][Medline]
Barth, A. I. M., Pollack, A. L., Altschuler, Y., Mostov, K. E.
and Nelson, W. J. (1997). NH2-terminal beletion of
beta-batenin results in stable colocalization of mutant beta-catenin with
adenomatous polyposis coli protein and altered MDCK cell adhesion.
J. Cell Biol. 136,693
-706.
Brons, I. G. M., Smithers, L. E., Trotter, M. W. B., Rugg-Gunn, P., Sun, B., Chuva de Sousa Lopes, S. M., Howlett, S. K., Clarkson, A., Ahrlund-Richter, L., Pedersen, R. A. et al. (2007). Derivation of pluripotent epiblast stem cells from mammalian embryos. Nature 448,191 -195.[CrossRef][Medline]
D'Amour, K. A., Agulnick, A. D., Eliazer, S., Kelly, O. G., Kroon, E. and Baetge, E. E. (2005). Efficient differentiation of human embryonic stem cells to definitive endoderm. Nat. Biotechnol. 23,1534 -1541.[CrossRef][Medline]
Derynck, R. and Zhang, Y. E. (2003). Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature 425,577 -584.[CrossRef][Medline]
Dravid, G., Ye, Z., Hammond, H., Chen, G., Pyle, A., Donovan,
P., Yu, X. and Cheng, L. (2005). Defining the role of
Wnt/beta-catenin signaling in the survival, proliferation, and self-renewal of
human embryonic stem cells. Stem Cells
23,1489
-1501.
Etienne-Manneville, S. and Hall, A. (2003). Cdc42 regulates GSK-3beta and adenomatous polyposis coli to control cell polarity. Nature 421,753 -756.[CrossRef][Medline]
Gadue, P., Huber, T. L., Paddison, P. J. and Keller, G. M.
(2006). Wnt and TGF-beta signaling are required for the induction
of an in vitro model of primitive streak formation using embryonic stem cells.
Proc. Natl. Acad. Sci. USA
103,16806
-16811.
Glinka, A., Wu, W., Delius, H., Monaghan, A. P., Blumenstock, C. and Niehrs, C. (1998). Dickkopf-1 is a member of a new family of secreted proteins and functions in head induction. Nature 391,357 -362.[CrossRef][Medline]
Gouon-Evans, V., Boussemart, L., Gadue, P., Nierhoff, D., Koehler, C. I., Kubo, A., Shafritz, D. A. and Keller, G. (2006). BMP-4 is required for hepatic specification of mouse embryonic stem cell-derived definitive endoderm. Nat. Biotechnol. 24,1402 -1411.[CrossRef][Medline]
Gurdon, J. B. and Bourillot, P. Y. (2001). Morphogen gradient interpretation. Nature 413,797 -803.[CrossRef][Medline]
Hao, J., Li, T. G., Qi, X., Zhao, D. F. and Zhao, G. Q. (2006). WNT/beta-catenin pathway up-regulates Stat3 and converges on LIF to prevent differentiation of mouse embryonic stem cells. Dev. Biol. 290,81 -91.[CrossRef][Medline]
He, X. C., Zhang, J., Tong, W.-G., Tawfik, O., Ross, J., Scoville, D. H., Tian, Q., Zeng, X., He, X., Wiedemann, L. M. et al. (2004). BMP signaling inhibits intestinal stem cell self-renewal through suppression of Wnt-beta-catenin signaling. Nat. Genet. 36,1117 -1121.[CrossRef][Medline]
James, D., Levine, A. J., Besser, D. and Hemmati-Brivanlou,
A. (2005). TGF-beta/activin/nodal signaling is necessary for
the maintenance of pluripotency in human embryonic stem cells.
Development 132,1273
-1282.
Jamora, C., DasGupta, R., Kocieniewski, P. and Fuchs, E. (2003). Links between signal transduction, transcription and adhesion in epithelial bud development. Nature 422,317 -322.[CrossRef][Medline]
Kanai-Azuma, M., Kanai, Y., Gad, J. M., Tajima, Y., Taya, C., Kurohmaru, M., Sanai, Y., Yonekawa, H., Yazaki, K., Tam, P. P. L. et al. (2002). Depletion of definitive gut endoderm in Sox17-null mutant mice. Development 129,2367 -2379.[Medline]
Keller, G. (2005). Embryonic stem cell
differentiation: emergence of a new era in biology and medicine.
Genes Dev. 19,1129
-1155.
Kemler, R., Hierholzer, A., Kanzler, B., Kuppig, S., Hansen, K.,
Taketo, M. M., de Vries, W. N., Knowles, B. B. and Solter, D.
(2004). Stabilization of beta-catenin in the mouse zygote leads
to premature epithelial-mesenchymal transition in the epiblast.
Development 131,5817
-5824.
Kobielak, K., Stokes, N., de la Cruz, J., Polak, L. and Fuchs,
E. (2007). Loss of a quiescent niche but not follicle stem
cells in the absence of bone morphogenetic protein signaling. Proc.
Natl. Acad. Sci. USA 104,10063
-10068.
Kubo, A., Shinozaki, K., Shannon, J. M., Kouskoff, V., Kennedy,
M., Woo, S., Fehling, H. J. and Keller, G. (2004).
Development of definitive endoderm from embryonic stem cells in culture.
Development 131,1651
-1662.
Laslo, P., Spooner, C. J., Warmflash, A., Lancki, D. W., Lee, H.-J., Sciammas, R., Gantner, B. N., Dinner, A. R. and Singh, H. (2006). Multilineage transcriptional priming and determination of alternate hematopoietic cell fates. Cell 126,755 -766.[CrossRef][Medline]
Lickert, H., Kutsch, S., Kanzler, B., Tamai, Y., Taketo, M. M. and Kemler, R. (2002). Formation of multiple hearts in mice following deletion of beta-catenin in the embryonic endoderm. Dev. Cell 3,171 -181.[CrossRef][Medline]
Lindsley, R. C., Gill, J. G., Kyba, M., Murphy, T. L. and
Murphy, K. M. (2006). Canonical Wnt signaling is required for
development of embryonic stem cell-derived mesoderm.
Development 133,3787
-3796.
Littlewood, T. D., Hancock, D. C., Danielian, P. S., Parker, M.
G. and Evan, G. I. (1995). A modified oestrogen receptor
ligand-binding domain as an improved switch for the regulation of heterologous
proteins. Nucleic Acids Res.
23,1686
-1690.
Meijer, L., Skaltsounis, A.-L., Magiatis, P., Polychronopoulos, P., Knockaert, M., Leost, M., Ryan, X. P., Vonica, C. A., Brivanlou, A., Dajani, R. et al. (2003). GSK-3-selective inhibitors derived from Tyrian purple indirubins. Chem. Biol. 10,1255 -1266.[CrossRef][Medline]
Messenger, N. J., Kabitschke, C., Andrews, R., Grimmer, D., Miguel, R. N., Blundell, T. L., Smith, J. C. and Wardle, F. C. (2005). Functional specificity of the Xenopus T-domain protein brachyury is conferred by its ability to interact with Smad1. Dev. Cell 8,599 -610.[CrossRef][Medline]
Mima, T., Ueno, H., Fischman, D. A., Williams, L. T. and Mikawa,
T. (1995). Fibroblast growth factor receptor is required for
in vivo cardiac myocyte proliferation at early embryonic stages of heart
development. Proc. Natl. Acad. Sci. USA
92,467
-471.
Moon, R. T., Kohn, A. D., Ferrari, G. V. D. and Kaykas, A. (2004). WNT and beta-catenin signalling: diseases and therapies. Nat. Rev. Genet. 5,691 -701.[CrossRef][Medline]
Murry, C. E. and Keller, G. (2008). Differentiation of embryonic stem cells to clinically relevant populations: lessons from embryonic development. Cell 132,661 -680.[Medline]
Niwa, H., Miyazaki, J.-i. and Smith, A. G. (2000). Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells. Nat. Genet. 24,372 -376.[CrossRef][Medline]
Nostro, M. C., Cheng, X., Keller, G. M. and Gadue, P. (2008). Wnt, Activin, and BMP signaling regulate distinct stages in the developmental pathway from embryonic stem cells to blood. Cell Stem Cell 2,60 -71.[CrossRef][Medline]
Poulain, M., Furthauer, M., Thisse, B., Thisse, C. and Lepage,
T. (2006). Zebrafish endoderm formation is regulated by
combinatorial Nodal, FGF and BMP signalling.
Development 133,2189
-2200.
Robb, L., Hartley, L., Begley, C. G., Brodnicki, T. C., Copeland, N. G., Gilbert, D. J., Jenkins, N. A. and Elefanty, A. G. (2000). Cloning, expression analysis, and chromosomal localization of murine and human homologues of a Xenopus Mix gene. Dev. Dyn. 219,497 -504.[CrossRef][Medline]
Sasai, Y., Lu, B., Piccolo, S. and De Robertis, E. M. (1996). Endoderm induction by the organizer-secreted factors chordin and noggin in Xenopus animal caps. EMBO J. 15,4547 -4555.[Medline]
Sato, N., Meijer, L., Skaltsounis, L., Greengard, P. and Brivanlou, A. H. (2004). Maintenance of pluripotency in human and mouse embryonic stem cells through activation of Wnt signaling by a pharmacological GSK-3-specific inhibitor. Nat. Med. 10, 55-63.[CrossRef][Medline]
Suemori, H., Yasuchika, K., Hasegawa, K., Fujioka, T., Tsuneyoshi, N. and Nakatsuji, N. (2006). Efficient establishment of human embryonic stem cell lines and long-term maintenance with stable karyotype by enzymatic bulk passage. Biochem. Biophys. Res. Commun. 345,926 -932.[CrossRef][Medline]
Sumi, T., Tsuneyoshi, N., Nakatsuji, N. and Suemori, H. (2007). Apoptosis and differentiation of human embryonic stem cells induced by sustained activation of c-Myc. Oncogene 26,5564 -5576.[CrossRef][Medline]
Tam, P. P. L. and Loebel, D. A. F. (2007). Gene function in mouse embryogenesis: get set for gastrulation. Nat. Rev. Genet. 8,368 -381.[CrossRef][Medline]
Tesar, P. J., Chenoweth, J. G., Brook, F. A., Davies, T. J., Evans, E. P., Mack, D. L., Gardner, R. L. and McKay, R. D. G. (2007). New cell lines from mouse epiblast share defining features with human embryonic stem cells. Nature 448,196 -199.[CrossRef][Medline]
Thiery, J. P. (2002). Epithelial-mesenchymal transitions in tumour progression. Nat. Rev. Cancer 2, 442-454.[CrossRef][Medline]
Tighe, A., Ray-Sinha, A., Staples, O. D. and Taylor, S. S. (2007). GSK-3 inhibitors induce chromosome instability. BMC Cell Biol. 8,34 -50.[CrossRef][Medline]
Ullmann, U., In't Veld, P., Gilles, C., Sermon, K., De Rycke,
M., Van de Velde, H., Van Steirteghem, A. and Liebaers, I.
(2007). Epithelial-mesenchymal transition process in human
embryonic stem cells cultured in feeder-free conditions. Mol. Hum.
Reprod. 13,21
-32.
Vincent, S. D., Dunn, N. R., Hayashi, S., Norris, D. P. and
Robertson, E. J. (2003). Cell fate decisions within the mouse
organizer are governed by graded Nodal signals. Genes
Dev. 17,1646
-1662.
Watanabe, S., Umehara, H., Murayama, K., Okabe, M., Kimura, T. and Nakano, T. (2006). Activation of Akt signaling is sufficient to maintain pluripotency in mouse and primate embryonic stem cells. Oncogene 25,2697 -2707.[CrossRef][Medline]
Yamaguchi, T. P., Takada, S., Yoshikawa, Y., Wu, N. and McMahon,
A. P. (1999). T (Brachyury) is a direct target of Wnt3a
during paraxial mesoderm specification. Genes Dev.
13,3185
-3190.
Yao, S., Chen, S., Clark, J., Hao, E., Beattie, G. M., Hayek, A.
and Ding, S. (2006). Long-term self-renewal and directed
differentiation of human embryonic stem cells in chemically defined
conditions. Proc. Natl. Acad. Sci. USA
103,6907
-6912.
Yao, Y., Li, W., Wu, J., Germann, U. A., Su, M. S. S., Kuida, K.
and Boucher, D. M. (2003). Extracellular signal-regulated
kinase 2 is necessary for mesoderm differentiation. Proc. Natl.
Acad. Sci. USA 100,12759
-12764.
Yasunaga, M., Tada, S., Torikai-Nishikawa, S., Nakano, Y., Okada, M., Jakt, L. M., Nishikawa, S., Chiba, T., Era, T. and Nishikawa, S. (2005). Induction and monitoring of definitive and visceral endoderm differentiation of mouse ES cells. Nat. Biotechnol. 23,1542 -1550.[CrossRef][Medline]
Zamparini, A. L., Watts, T., Gardner, C. E., Tomlinson, S. R.,
Johnston, G. I. and Brickman, J. M. (2006). Hex acts with
beta-catenin to regulate anteroposterior patterning via a Groucho-related
co-repressor and Nodal. Development
133,3709
-3722.
Zhang, H. and Bradley, A. (1996). Mice deficient for BMP2 are nonviable and have defects in amnion/chorion and cardiac development. Development 122,2977 -2986.[Abstract]
Related articles in Development:
This article has been cited by other articles:
![]() |
Y. Xia and A. L Schneyer The biology of activin: recent advances in structure, regulation and function J. Endocrinol., July 1, 2009; 202(1): 1 - 12. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Irion, M.C. Nostro, S.J. Kattman, and G.M. Keller Directed Differentiation of Pluripotent Stem Cells: From Developmental Biology to Therapeutic Applications Cold Spring Harb Symp Quant Biol, March 27, 2009; (2009) sqb.2008.73.065v1. [Abstract] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||